Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Tolerability and safety of Octagam® (IVIG): a post-authorization safety analysis of four non-interventional phase IV trials
.
Int J Clin Pharmacol Ther. 2016 Nov;54(11):847-855. doi: 10.5414/CP202782.
Int J Clin Pharmacol Ther. 2016.
PMID: 27719744
Free PMC article.
Clinical Trial.
Tolerability and safety of the intravenous immunoglobulin octagam® 10% in patients with immune thrombocytopenia: a post-authorisation safety analysis of two non-interventional phase IV trials.
Wietek S, Svorc D, Debes A, Svae TE.
Wietek S, et al. Among authors: svorc d.
Hematology. 2018 May;23(4):242-247. doi: 10.1080/10245332.2017.1385892. Epub 2017 Oct 11.
Hematology. 2018.
PMID: 29020871
Clinical Trial.
Item in Clipboard
Cite
Cite